NC Biomatrix
PrivateLast Round
Grant
Feb 2, 2023
Total Funding Raised
$3.76M
Company Overview
NC Biomatrix operates in Healthcare & Life Sciences and is based in Eindhoven. Its latest recorded funding round was a Grant round in February 2023.
NC Biomatrix is a biotechnology company developing a non-invasive, injectable biomaterial to treat chronic back pain caused by degenerative disc disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NC Biomatrix Comparables
Compare NC Biomatrix with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ReGelTec, Inc. | 84% | |
| Notogen Inc. | 84% | |
| OrthoSon | 84% |
For institutional investors. Book with your work email.
NC Biomatrix Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 2, 2023 | ||||
| VC Round | Feb 14, 2022 | ||||
| Grant | Jul 16, 2021 | ||||
| Debt | Jul 12, 2021 | ||||
| Debt | Apr 1, 2020 | ||||
Debt | Feb 25, 2020 |
For institutional investors. Book with your work email.
NC Biomatrix Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| Netherlands Organization for Scientific Research | Debt |
| DSM Venturing | VC Round |
| Brabant Startup Fonds | Debt |
| dsm-firmenich Venturing | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 15, 2026
Monthly visitors grew 143% MoM, reaching 1.3K.
- Feb 2, 2023
Received $2.68M from the European Innovation Council.
For institutional investors. Book with your work email.
NC Biomatrix Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about NC Biomatrix's valuation, stock price, and market status.
Is NC Biomatrix a public or private company?
NC Biomatrix is a private company.
What is the current stock price of NC Biomatrix?
NC Biomatrix is a private company, so its shares have no public market price. Caplight tracks NC Biomatrix's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is NC Biomatrix worth (valuation)?
Valuation information for NC Biomatrix is not publicly available.
Can I buy NC Biomatrix stock?
NC Biomatrix shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was NC Biomatrix's last funding round?
NC Biomatrix's most recent funding round was Grant on February 2, 2023.
Who are the main investors in NC Biomatrix?
Key investors in NC Biomatrix include DSM Venturing, Brabant Startup Fonds, dsm-firmenich Venturing.
Will NC Biomatrix IPO soon?
No public IPO plans have been announced for NC Biomatrix.
How can I track NC Biomatrix secondary market activity?
Caplight tracks bids, offers, and trades in NC Biomatrix's shares on secondary markets.